DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients
Phase 1
Completed
- Conditions
- Type2 Diabetes
- Interventions
- Drug: DCB-DM101
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- VitNovo, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT03033433
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath